BBC Fees and Costs — Virtus LifeSci Biotech Clinical Trials ETF

Data updated: 2026-09-29

The net expense ratio is 0.65%. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $16K in broker commissions, 0.1292% of average net assets, and portfolio turnover was 53%.

BBC Fees and Expenses

Annual operating expenses and sales charges of BBC. Prospectus, as of February 26, 2026.

Annual operating expenses
Management fee0.65%
12b-1 fee—
Other expenses—
Gross expense ratio0.65%
Fee waiver—
Net expense ratio0.65%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)No
Fees waived or reduced during the yearNo
Waived fees subject to recoupmentNo

BBC Costs Over Time

On $10,000 invested in BBC, assuming 5% a year before costs, total costs come to $490 over 5 years, cutting the return by 0.82% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 0.65%)$68$213$371
Trading costs (broker commissions)$14$42$74
Lost growth on money paid in costs$0$13$45
Total costs$82$269$490
Value after costs$10,418$11,308$12,273
Impact on return, per year0.82%0.82%0.82%

BBC Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2025.

  • Explicit cost rate (commissions ÷ average net assets): 0.1292%
  • Total broker commissions: $16K
  • Bought from dealers (principal trades, not a cost): $38.8M
  • Portfolio turnover (prospectus): 53%
  • Securities on loan, average value: $2.4M
  • Net income from securities lending: $56K (0.442% of average net assets)

BBC Agency Brokers

Commissions paid.

BrokerAmountShare
VIRTU AMERICAS LLC$16K95.82%
Jane Street Execution Services, LLC$6834.18%

BBC Dealer Counterparties

Securities bought directly from dealers (principal trades).

BrokerAmountShare
BOFA SECURITIES, INC.$21.8M41.94%
VIRTU AMERICAS LLC$21.8M41.94%
GOLDMAN SACHS & CO. LLC$6.6M12.67%
CITADEL SECURITIES LLC$1.8M3.44%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.